Julphar reported sales of 883.1 million

According to Amac news: The report said Julphar reported strong sales growth in the first half of the year, which was directed by a very strong second trimester.
The sales of the company for the first half of 2024 reached 883.1 million AEDs, indicating a 2.8 percent growth. At Q2, sales reached 444.0 million AEDs and showed 9.5 percent growth compared to the previous quarter (10.1 percent in constant currency).
Revenue through our retail and wholesale pharmacies, the planet's pharmacies, still shows a sharp growth in reaching 576.9 million AEDs for the first time, indicating an increase of 8.4 percent compared to the same period last year.
During the first half of the year, the company has reduced its main net losses before the taxation of 42.8 million AEDs moving from AED -40.5 million in H1'23 to AED +2.3 million for the current year and decrease EBITDA from the first half of the year Data.
In addition, Julphar reported a report of intense cash flow and reached 101.0 million AEDs, compared to AED -15.7 million in the same period last year by efficiency initiatives and increased focus on capital management.